The mechanism of action of cairomycin B.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000096:biosynthesis*; D004269:DNA, Bacterial / Q000096:biosynthesis*; D012321:DNA-Directed RNA Polymerases / Q000378:metabolism; D007700:Kinetics; D007930:Leucine / Q000378:metabolism; D008239:Lysine / Q000378:metabolism; D010442:Peptide Chain Initiation, Translational / Q000187:drug effects; D010456:Peptides, Cyclic / Q000494:pharmacology; D014176:Protein Biosynthesis / Q000187:drug effects; D012329:RNA, Bacterial / Q000096:biosynthesis*; D013211:Staphylococcus aureus / Q000187:drug effects / Q000378:metabolism*; D013936:Thymidine / Q000378:metabolism; D014529:Uridine / Q000378:metabolism
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D004269:DNA, Bacterial; D010456:Peptides, Cyclic; D012329:RNA, Bacterial; D012321:DNA-Directed RNA Polymerases; D007930:Leucine; D008239:Lysine; D013936:Thymidine; D014529:Uridine